|
1
|
Brennan B: Nasopharyngeal carcinoma.
Orphanet J Rare Dis. 1:23–28. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bruce JP, Yip K, Bratman SV, Ito E and Liu
FF: Nasopharyngeal cancer: Molecular landscape. J Clin Oncol.
33:3346–3355. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thompson L: World Health Organization
classification of tumours: Pathology and genetics of head and neck
tumours. Ear Nose Throat J. 85:742006.PubMed/NCBI
|
|
6
|
Hutvágner G and Zamore PD: A microRNA in a
multiple-turnover RNAi enzyme complex. Science. 297:2056–2060.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Y and Kowdley KV: MicroRNAs in common
human diseases. Genomics Proteomics Bioinformatics. 10:246–253.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
OConnell RM, Rao DS and Baltimore D:
microRNA regulation of inflammatory responses. Annu Rev Immunol.
30:295–312. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Henson BJ, Bhattacharjee S, ODee DM,
Feingold E and Gollin SM: Decreased expression of miR-125b and
miR-100 in oral cancer cells contributes to malignancy. Genes
Chromosomes Cancer. 48:569–582. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng YS, Zhang H, Zhang XJ, Feng DD, Luo
XQ, Zeng CW, Lin KY, Zhou H, Qu LH, Zhang P, et al: MiR-100
regulates cell differentiation and survival by targeting RBSP3, a
phosphatase-like tumor suppressor in acute myeloid leukemia.
Oncogene. 31:80–92. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kashuba VI, Li J, Wang F, Senchenko VN,
Protopopov A, Malyukova A, Kutsenko AS, Kadyrova E, Zabarovska VI,
Muravenko OV, et al: RBSP3 (HYA22) is a tumor suppressor gene
implicated in major epithelial malignancies. Proc Natl Acad Sci
USA. 101:4906–4911. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Samani AA, Yakar S, LeRoith D and Brodt P:
The role of the IGF system in cancer growth and metastasis:
Overview and recent insights. Endocr Rev. 28:20–47. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Casa AJ, Dearth RK, Litzenburger BC, Lee
AV and Cui X: The type I insulin-like growth factor receptor
pathway: a key player in cancer therapeutic resistance. Front
Biosci. 13:3273–3287. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Steele-Perkins G, Turner J, Edman JC, Hari
J, Pierce SB, Stover C, Rutter WJ and Roth RA: Expression and
characterization of a functional human insulin-like growth factor I
receptor. J Biol Chem. 263:11486–11492. 1988.PubMed/NCBI
|
|
16
|
Dziadziuszko R, Merrick DT, Witta SE,
Mendoza AD, Szostakiewicz B, Szymanowska A, Rzyman W, Dziadziuszko
K, Jassem J, Bunn PA Jr, et al: Insulin-like growth factor receptor
1 (IGF1R) gene copy number is associated with survival in operable
non-small-cell lung cancer: A comparison between IGF1R fluorescent
in situ hybridization, protein expression, and mRNA expression. J
Clin Oncol. 28:2174–2180. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yuen JS, Cockman ME, Sullivan M, Protheroe
A, Turner GD, Roberts IS, Pugh CW, Werner H and Macaulay VM: The
VHL tumor suppressor inhibits expression of the IGF1R and its loss
induces IGF1R upregulation in human clear cell renal carcinoma.
Oncogene. 26:6499–6508. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Katanoda K and Marugame T: Comparison of
time trends in cancer incidence (1973-1997) in East Asia, Europe
and USA, from Cancer Incidence in Five Continents Vol. IV–VIII. Jpn
J Clin Oncol. 37:157–159. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jia WH, Huang QH, Liao J, Ye W, Shugart
YY, Liu Q, Chen LZ, Li YH, Lin X, Wen FL, et al: Trends in
incidence and mortality of nasopharyngeal carcinoma over a 20–25
year period (1978/1983-2002) in Sihui and Cangwu counties in
southern China. BMC Cancer. 6:1782006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen R, Zhang M, Li Q, Xiong H, Liu S,
Fang W, Zhang Q, Liu Z, Xu X and Jiang Q: The Epstein-Barr
Virus-encoded miR-BART22 targets MAP3K5 to promote host cell
proliferative and invasive abilities in nasopharyngeal carcinoma. J
Cancer. 8:305–313. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang P, Hong H, Sun X, Jiang H, Ma S,
Zhao S, Zhang M, Wang Z, Jiang C and Liu H: MicroRNA-10b regulates
epithelial-mesenchymal transition by modulating
KLF4/Notch1/E-cadherin in cisplatin-resistant nasopharyngeal
carcinoma cells. Am J Cancer Res. 6:141–156. 2016.PubMed/NCBI
|
|
22
|
Cheung CC, Lun SW, Chung GT, Chow C, Lo C,
Choy KW and Lo KW: MicroRNA-183 suppresses cancer stem-like cell
properties in EBV-associated nasopharyngeal carcinoma. BMC Cancer.
16:4952016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu K, He Y, Xia C, Yan J, Hou J, Kong D,
Yang Y and Zheng G: MicroRNA-15a inhibits proliferation and induces
apoptosis in CNE1 nasopharyngeal carcinoma cells. Oncol Res.
24:145–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Torres A, Torres K, Pesci A, Ceccaroni M,
Paszkowski T, Cassandrini P, Zamboni G and Maciejewski R:
Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma
coexists with increased expression of mTOR kinase in endometrioid
endometrial carcinoma. BMC Cancer. 12:3692012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sell C, Rubini M, Rubin R, Liu JP,
Efstratiadis A and Baserga R: Simian virus 40 large tumor antigen
is unable to transform mouse embryonic fibroblasts lacking type 1
insulin-like growth factor receptor. Proc Natl Acad Sci USA.
90:11217–11221. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou H, Qian W, Uckun FM, Wang L, Wang YA,
Chen H, Kooby D, Yu Q, Lipowska M, Staley CA, et al: IGF1 receptor
targeted theranostic nanoparticles for targeted and image-guided
therapy of pancreatic cancer. ACS Nano. 9:7976–7991. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
IGF1R signaling is a therapeutic target in
ALK fusion-positive lung cancer. Cancer Discov. 4:12512014.
View Article : Google Scholar
|
